Values First Advisors, Inc. Axsome Therapeutics, Inc. Transaction History
Values First Advisors, Inc.
- $182 Million
- Q3 2024
A detailed history of Values First Advisors, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 6,322 shares of AXSM stock, worth $598,061. This represents 0.31% of its overall portfolio holdings.
Number of Shares
6,322Holding current value
$598,061% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$396 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$378 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$312 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$223 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$99 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.06B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...